/PRNewswire/ -- The report has been added to offering.
Benchmarks closed in the green as investors shrugged off inflation report in agreement with the Fed's argument that jump in prices is temporary as demand exceed supply on account of the economy's recovery...
-- Dense, Stable, Low Power Data Storage in DNA Provides Option to Traditional Storage --
The Zacks Analyst Blog Highlights: Intel, NextEra Energy, PetroChina, Illumina and Biogen
Top Research Reports for Intel, NextEra Energy & PetroChina
Increasing awareness about utilization of genetic tests and integration of predictive genetic testing with advanced technology are factors expected to drive market growth.
Japan, Japan, Fri, 04 Jun 2021 02:51:54 / Comserve Inc. / -- Global Bioinformatics Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies,...
LHC Group (LHCG) agrees to purchase Heart of Hospice to extend its hospice footprint in five states.
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.
The rising demand for COVID-19 vaccines worldwide has been pushing biotech companies with successful vaccine candidates to increase their production capacities. Also, rising demand for COVID-19 treatments...
Investors continue to be optimistic about PRA Health (PRAH) owing to its strategic alliances and solid CRO market prospects.
Baxter's (BAX) PrisMax 2 aims to enhance user experience and help in addressing the unique demands of the ICU.
Illumina's (ILMN) VeriSeq NIPT Solution v2 provides accurate, consistent and scalable end-to-end genome-wide noninvasive prenatal testing.
Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or...
Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in laboratory...
BD's (BDX) UCA leverages AI to revolutionize the way microbiology labs conduct urine culture analysis.
Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.
Bristol Myers (BMY) gets FDA approval for Zeposia to treat adults with moderate-to-severe active ulcerative colitis. This marks the second indication for the drug.
Change Healthcare's (CHNG) fiscal fourth-quarter results benefit from solid performance in the Network Solutions segment.